1. HIV Drugs Market Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
7. Segmentation By Geography
7.1 Segmentation By Type
7.2 Segmentation By Application
7.3 Segmentation By Administration
8. HIV Drugs Market Characteristics
8.1 Market Definition
8.2 Market Segmentation By Type
8.2.1 Nucleoside Reverse Transcriptase Inhibitors (NRT’s)
8.2.2 Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)
8.2.3 Protease Inhibitors
8.2.4 Integrase strand transfer inhibitors (INSTIs)
8.2.5 Others
8.3 Market Segmentation By Application
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Others
8.4 Market Segmentation By Administration
8.4.1 Oral
8.4.2 Parenteral
9 HIV Drugs Market Trends And Strategies
9.1 Multi-Class Combination Products For HIV Treatment
9.2 3D Bioprinting Technology
9.3 Increasing Number Of Pipeline Studies And Drug Development
9.4 Global Research Initiatives And Funding
9.5 New Product Innovations
9.6 Strategic Collaborations And Agreements
10 Impact Of COVID-19 On The HIV Drugs Market
10.1 Consumer Perception
10.2 High Mortality Among HIV/AIDS Patients
10.3 COVID-19 Impact On HIV Treatment
10.4 High Demand for HIV And Anti-viral Drugs During COVID-19 Outbreak
10.5 Conclusion
11 Global HIV Drugs Market Size And Growth
11.1 Market Size
11.2 Historic Market Growth, 2015 – 2020, Value ($ Million)
11.2.1 Drivers Of The Market 2015 – 2020
11.2.2 Restraints On The Market 2015 – 2020
11.3 Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
11.3.1 Drivers Of The Market 2020 – 2025
11.3.2 Restraints On The Market 2020 – 2025
12 Global HIV Drugs Market Segmentation
12.1 Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12.1.1 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
12.1.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
12.1.3 Integrase Strand Transfer Inhibitors (INSTIs)
12.1.4 Protease Inhibitors (PIs)
12.1.5 Others
12.2 Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12.2.1 Hospital Pharmacies
12.2.2 Retail Pharmacies
12.2.3 Others
12.3 Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12.3.1 Oral
12.3.2 Parenteral
13 HIV Drugs Market, Regional And Country Analysis
13.1 Global HIV Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.2 Global HIV Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14 Asia-Pacific HIV Drugs Market
14.1 Asia-Pacific HIV Drugs Market Overview
14.1.1 Region Information
14.1.2 Market Information
14.1.3 COVID-19 Impact
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Asia-Pacific HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.3 Asia-Pacific HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.4 Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.5 Asia-Pacific HIV Drugs Market: Country Analysis
14.6 China HIV Drugs Market
14.7 China HIV Drugs Market Overview
14.7.1 Country Information
14.7.2 Market Information
14.7.3 COVID-19 Impact
14.7.4 Background Information
14.7.5 Government Initiatives
14.7.6 Regulations
14.7.7 Regulatory Bodies
14.7.8 Major Associations
14.7.9 Taxes levied
14.7.10 Corporate Tax Structure
14.7.11 Investments
14.7.12 Major Companies
14.8 China HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.9 China HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.10 China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.11 India HIV Drugs Market
14.12 India HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.13 India HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.14 India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.15 Japan HIV Drugs Market
14.16 Japan HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.17 Japan HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.18 Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.19 Australia HIV Drugs Market
14.20 Australia HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.21 Australia HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.22 Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.23 Indonesia HIV Drugs Market
14.24 Indonesia HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.25 Indonesia HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.26 Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.27 South Korea HIV Drugs Market
14.28 South Korea HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.29 South Korea HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.30 South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15 Western Europe HIV Drugs Market
15.1 Western Europe HIV Drugs Market Overview
15.1.1 Region Information
15.1.2 Market Information
15.1.3 COVID-19 Impact
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 Western Europe HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.3 Western Europe HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.4 Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.5 Western Europe HIV Drugs Market: Country Analysis
15.6 UK HIV Drugs Market
15.7 UK HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.8 UK HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.9 UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.10 Germany HIV Drugs Market
15.11 Germany HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.12 Germany HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.13 Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.14 France HIV Drugs Market
15.15 France HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.16 France HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.17 France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16 Eastern Europe HIV Drugs Market
16.1 Eastern Europe HIV Drugs Market Overview
16.1.1 Region Information
16.1.2 Market Information
16.1.3 COVID-19 Impact
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Tax Levied
16.1.9 Major Associations
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 Eastern Europe HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.3 Eastern Europe HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
16.4 Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.5 Eastern Europe HIV Drugs Market: Country Analysis
16.6 Russia HIV Drugs Market
16.7 Russia HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.8 Russia HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
16.9 Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17 North America HIV Drugs Market
17.1 North America HIV Drugs Market Overview
17.1.1 Region Information
17.1.2 Market Information
17.1.3 COVID-19 Impact
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 North America HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
17.3 North America HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
17.4 North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.5 North America HIV Drugs Market: Country Analysis
17.6 USA HIV Drugs Market
17.6.1 USA HIV Drugs Market Overview
17.6.2 Country Information
17.6.3 Market Information
17.6.4 COVID-19 Impact
17.6.5 Background Information
17.6.6 Government Initiatives
17.6.7 Regulations
17.6.8 Regulatory Bodies
17.6.9 Major Associations
17.6.10 Corporate Tax Structure
17.6.11 Investments
17.6.12 Major Companies
17.7 USA HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
17.8 USA HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
17.9 USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18 South America HIV Drugs Market
18.1 South America HIV Drugs Market Overview
18.1.1 Region Information
18.1.2 Market Information
18.1.3 COVID-19 Impact
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Tax Levied
18.1.9 Major Associations
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 South America HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.3 South America HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.4 South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.5 South America HIV Drugs Market: Country Analysis
18.6 Brazil HIV Drugs Market
18.7 Brazil HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.8 Brazil HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.9 Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19 Middle East HIV Drugs Market
19.1 Middle East HIV Drugs Market Overview
19.1.1 Region Information
19.1.2 Market Information
19.1.3 COVID-19 Impact
19.1.4 Background Information
19.1.5 Government Initiatives
19.1.6 Regulations
19.1.7 Regulatory Bodies
19.1.8 Major Associations
19.1.9 Taxes Levied
19.1.10 Corporate Tax Structure
19.1.11 Investment
19.1.12 Major Companies
19.2 Middle East HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.3 Middle East HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.4 Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20 Africa HIV Drugs Market
20.1 Africa HIV Drugs Market Overview
20.1.1 Region Information
20.1.2 Market Information
20.1.3 COVID-19 Impact
20.1.4 Background Information
20.1.5 Government Initiatives
20.1.6 Regulations
20.1.7 Regulatory Bodies
20.1.8 Major Associations
20.1.9 Taxes Levied
20.1.10 Corporate Tax Structure
20.1.11 Investments
20.1.12 Major Companies
20.2 Africa HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.3 Africa HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.4 Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21 Global HIV Drugs Market Competitive Landscape
21.1 Company Profiles
21.2 Gilead Sciences, Inc.
21.2.1 Company Overview
21.2.2 Products And Services
21.2.3 Business Strategy
21.2.4 Financial Overview
21.3 GlaxoSmithKline
21.3.1 Company Overview
21.3.2 Products And Services
21.3.3 Business Strategy
21.3.4 Financial Overview
21.4 Johnson & Johnson
21.4.1 Company Overview
21.4.2 Products And Services
21.4.3 Business Strategy
21.4.4 Financial Overview
21.5 Merck & Co., Inc.
21.5.1 Company Overview
21.5.2 Products And Services
21.5.3 Business Strategy
21.5.4 Financial Overview
21.6 Boehringer Ingelheim International GmbH
21.6.1 Company Overview
21.6.2 Products And Services
21.6.3 Financial Overview
22 Key Mergers And Acquisitions In The HIV Drugs Market
22.1 Gilead Sciences Partnered With Gritstone Oncology
22.2 Beximco Pharmaceuticals Acquired Stakes in Sanofi Bangladesh
22.3 CytoDyn Inc. Collaborates With amfAR
22.4 Merck Partnered With Dewpoint Therapeutics
22.5 ViiV Healthcare Collaborated With Chapel Hill
22.6 HOOKIPA Pharma Inc. Partners With Gilead Sciences
22.7 Lyndra Therapeutics Collaborates With Gilead Sciences
22.8 Mylan Acquired Ascendis Health
22.9 Mylan Collaborate With Atomo Diagnostics
22.10 ViiV Healthcare To Collaborate With Janssen
23 HIV Drugs Market Opportunities And Strategies
23.1 Global HIV Drugs Market In 2025 – Countries Offering Most New Opportunities
23.2 Global HIV Drugs Market In 2025 – Segments Offering Most New Opportunities
23.3 Global HIV Drugs Market In 2025 – Growth Strategies
23.3.1 Market Trend Based Strategies
23.3.2 Competitor Strategies
24 HIV Drugs Market Conclusions And Recommendations
24.1 Conclusions
24.2 Recommendations
24.2.1 Product
24.2.2 Place
24.2.3 Price
24.2.4 Promotion
24.2.5 People
25 Appendix
25.1.1 Market Data Sources
25.1.2 Research Methodology
25.1.3 Currencies
25.1.4 Research Inquiries
25.1.5 The Business Research Company
25.1.6 Copyright and Disclaimer